These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 21334676

  • 1. Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer.
    Koike H, Morikawa Y, Sekine Y, Matsui H, Shibata Y, Suzuki K.
    J Urol; 2011 Apr; 185(4):1497-503. PubMed ID: 21334676
    [Abstract] [Full Text] [Related]

  • 2. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
    Zhang M, Mukherjee N, Bermudez RS, Latham DE, Delaney MA, Zietman AL, Shipley WU, Chakravarti A.
    Prostate; 2005 Aug 01; 64(3):293-302. PubMed ID: 15754318
    [Abstract] [Full Text] [Related]

  • 3. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.
    Stewart LV, Weigel NL.
    Prostate; 2005 Jun 15; 64(1):9-19. PubMed ID: 15651061
    [Abstract] [Full Text] [Related]

  • 4. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.
    Pennati M, Binda M, Colella G, Zoppe' M, Folini M, Vignati S, Valentini A, Citti L, De Cesare M, Pratesi G, Giacca M, Daidone MG, Zaffaroni N.
    Oncogene; 2004 Jan 15; 23(2):386-94. PubMed ID: 14724567
    [Abstract] [Full Text] [Related]

  • 5. 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells.
    Schwartz GG, Wang MH, Zang M, Singh RK, Siegal GP.
    Cancer Epidemiol Biomarkers Prev; 1997 Sep 15; 6(9):727-32. PubMed ID: 9298581
    [Abstract] [Full Text] [Related]

  • 6. 1,25-dihydroxyvitamin D3 transcriptionally represses p45Skp2 expression via the Sp1 sites in human prostate cancer cells.
    Huang YC, Hung WC.
    J Cell Physiol; 2006 Nov 15; 209(2):363-9. PubMed ID: 16883603
    [Abstract] [Full Text] [Related]

  • 7. Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression.
    López-Boado YS, Puente XS, Alvarez S, Tolivia J, Binderup L, López-Otín C.
    Cancer Res; 1997 Sep 15; 57(18):4091-7. PubMed ID: 9307298
    [Abstract] [Full Text] [Related]

  • 8. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
    Zhang M, Latham DE, Delaney MA, Chakravarti A.
    Oncogene; 2005 Apr 07; 24(15):2474-82. PubMed ID: 15735703
    [Abstract] [Full Text] [Related]

  • 9. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.
    Myrthue A, Rademacher BL, Pittsenbarger J, Kutyba-Brooks B, Gantner M, Qian DZ, Beer TM.
    Clin Cancer Res; 2008 Jun 01; 14(11):3562-70. PubMed ID: 18519790
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y.
    Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583
    [Abstract] [Full Text] [Related]

  • 11. Human prostate cancer cells: inhibition of proliferation by vitamin D analogs.
    Schwartz GG, Oeler TA, Uskoković MR, Bahnson RR.
    Anticancer Res; 1994 Aug 15; 14(3A):1077-81. PubMed ID: 8074453
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.
    Golovko O, Nazarova N, Tuohimaa P.
    Life Sci; 2005 Jun 17; 77(5):562-77. PubMed ID: 15904673
    [Abstract] [Full Text] [Related]

  • 13. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 Jun 17; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 14. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.
    Clin Cancer Res; 2000 Mar 17; 6(3):901-8. PubMed ID: 10741714
    [Abstract] [Full Text] [Related]

  • 15. Livin-α promotes cell proliferation by regulating G1-S cell cycle transition in prostate cancer.
    Ye L, Song X, Li S, Yang D, Zhang J, Che X, Chen X, Wang J, Zhang Z.
    Prostate; 2011 Jan 01; 71(1):42-51. PubMed ID: 20607788
    [Abstract] [Full Text] [Related]

  • 16. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
    Barreto AM, Schwartz GG, Woodruff R, Cramer SD.
    Cancer Epidemiol Biomarkers Prev; 2000 Mar 01; 9(3):265-70. PubMed ID: 10750664
    [Abstract] [Full Text] [Related]

  • 17. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.
    Koike H, Sekine Y, Kamiya M, Nakazato H, Suzuki K.
    Urology; 2008 Dec 01; 72(6):1229-33. PubMed ID: 18336887
    [Abstract] [Full Text] [Related]

  • 18. 1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells.
    Serda RE, Bisoffi M, Thompson TA, Ji M, Omdahl JL, Sillerud LO.
    Prostate; 2008 May 15; 68(7):773-83. PubMed ID: 18247401
    [Abstract] [Full Text] [Related]

  • 19. Association of cooking oil fumes exposure with lung cancer: involvement of inhibitor of apoptosis proteins in cell survival and proliferation in vitro.
    Hung HS, Wu WJ, Cheng YW, Wu TC, Chang KL, Lee H.
    Mutat Res; 2007 Apr 02; 628(2):107-16. PubMed ID: 17229588
    [Abstract] [Full Text] [Related]

  • 20. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A.
    Cancer Res; 2000 Apr 15; 60(8):2304-12. PubMed ID: 10786699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.